
Adalia Pharmaceuticals LLP
About Adalia Pharmaceuticals LLP
Data last updated:
Adalia Pharmaceuticals LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 November 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAH-7912. Its GSTIN is 06ABGFA7454D1ZM (Haryana).
The LLP has a total obligation of contribution of ₹2 Lakh. It is led by designated partners Arvind Kumar Ajai Minz and Micah Nath.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at E – 70 Sarita Vihar, New Delhi, Delhi, India – 110076.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE – 70 Sarita Vihar, New Delhi, Delhi, India – 110076
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Adalia Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Adalia Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Adalia Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Adalia Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Adalia Pharmaceuticals LLP
Adalia Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Ajai Minz | Designated Partner | 10 Nov 2016 | 9 Years 11 Months | Current |
| Micah Nath | Designated Partner | 10 Nov 2016 | 9 Years 11 Months | Current |
Charges & Borrowings of Adalia Pharmaceuticals LLP
Adalia Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Adalia Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Adalia Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Adalia Pharmaceuticals LLP
Adalia Pharmaceuticals LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Arvind Kumar Ajai Minz was appointed as Designated Partner on 10 Nov 2016.
Credit Ratings, Litigation & Regulatory Alerts for Adalia Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Adalia Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Adalia Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Adalia Pharmaceuticals LLP
Adalia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06ABGFA7454D1ZM | Haryana | Active | 14 Jul 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Adalia Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adalia Pharmaceuticals LLP
Adalia Pharmaceuticals is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 10 November 2016 (10+ years old) and is registered under LLPIN AAH-7912.
Adalia Pharmaceuticals has 2 current designated partners:
- Arvind Kumar Ajai Minz - Designated Partner
- Micah Nath - Designated Partner
The GSTIN of Adalia Pharmaceuticals is 06ABGFA7454D1ZM, registered in Haryana.
The LLPIN (Limited Liability Partnership Identification Number) of Adalia Pharmaceuticals is AAH-7912. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Adalia Pharmaceuticals was incorporated on 10 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Arvind Kumar Ajai Minz was appointed as Designated Partner on 10 Nov 2016. Micah Nath was appointed as Designated Partner on 10 Nov 2016.
The registered office of Adalia Pharmaceuticals is at E – 70 Sarita Vihar, New Delhi, Delhi, India – 110076.
The total obligation of contribution is ₹2 Lakh.
Adalia Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Adalia Pharmaceuticals can be reached at its registered office: E – 70 Sarita Vihar, New Delhi, Delhi, India – 110076.